UroGen Pharma (URGN) Earnings (2018 - 2026)
UroGen Pharma (URGN) earnings from Mar 31, 2018 to Mar 31, 2026. The TTM UroGen Pharma (URGN) earnings is -$133M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
UroGen Pharma (URGN) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +171.55% |
| 3 Years TTM | +6.08% |
| 5 Years TTM | +2.70% |
| All Time TTM | +6.86% |
Annual Earnings change of UroGen Pharma (URGN)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$24M | -84.64% |
| 2025 | -$153M | +309.20% |
| 2024 | -$38M | +44.16% |
| 2023 | -$26M | -76.30% |
| 2022 | -$110M | -0.94% |
| 2021 | -$111M | -13.75% |
| 2020 | -$128M | +22.19% |
| 2019 | -$105M | +38.98% |
| 2018 | -$76M | +278.30% |
| 2017 | -$20M | +930.93% |
| 2016 | -$1.94M | -84.71% |
| 2015 | -$13M | N/A |
Comparison UroGen Pharma (URGN) five years earnings CAGR with competitors
UroGen Pharma (URGN) five years earnings CAGR is 2.70%.